Harvey Wong Selected Research

thyroxine glucuronide

4/2009

Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harvey Wong Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 04/2009
6	Rheumatoid Arthritis 08/2020 - 07/2011
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2017
3	Breast Neoplasms (Breast Cancer) 05/2012 - 03/2009
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 08/2015
2	Inflammation (Inflammations) 01/2017 - 01/2013
2	Basal Cell Carcinoma (Rodent Ulcer) 08/2014 - 03/2014
2	Ataxia (Dyssynergia) 01/2005 - 04/2004
1	Hyponatremia 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Anemia 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Neutropenia 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Hemophilia B (Haemophilia B) 01/2021
1	Immune System Diseases (Immune Disorders) 08/2020
1	Arthritis (Polyarthritis) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2017
1	Nephritis 01/2017
1	Atrophy 01/2017
1	Hemorrhage 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Epilepsy (Aura) 05/2014
1	Hypersensitivity (Allergy) 04/2014
1	Necrosis 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011
1	Medulloblastoma 07/2011
1	Experimental Arthritis 07/2011
1	Melanoma (Melanoma, Malignant) 04/2009
1	Colonic Neoplasms (Colon Cancer) 04/2009
1	Carcinogenesis 04/2009
1	Hypothyroidism 04/2009
1	Cardiomyopathies (Cardiomyopathy) 06/2006
1	Thrombosis (Thrombus) 06/2006
1	Disease Progression 06/2006
1	Anxiety Disorders (Anxiety Disorder) 04/2004

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2022 - 04/2011
4	Agammaglobulinaemia Tyrosine KinaseIBA 08/2020 - 07/2011
4	HhAntag691IBA 08/2014 - 04/2011
4	Proteins (Proteins, Gene)FDA Link 12/2013 - 05/2012
3	fenebrutinibIBA 08/2020 - 01/2017
2	Cytotoxins (Cytolysins)IBA 01/2022 - 07/2012
2	EnzymesIBA 01/2022 - 05/2014
2	Phosphotransferases (Kinase)IBA 01/2022 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 01/2013 - 09/2010
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2005 - 04/2004
2	Chlordiazepoxide (Elenium)FDA LinkGeneric 01/2005 - 04/2004
1	IntegrinsIBA 01/2022
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022
1	CamptothecinIBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	Cyclin-Dependent Kinase 9IBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2021
1	AmidesIBA 08/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2015
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2015
1	Phenytoin (Dilantin)FDA LinkGeneric 05/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2014
1	Dexmedetomidine FDA Link 05/2014
1	Hypnotics and Sedatives (Sedatives)IBA 05/2014
1	cremophor ELIBA 04/2014
1	Ethanol (Ethyl Alcohol)IBA 04/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2014
1	pyrrolidineIBA 12/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	ChemokinesIBA 01/2013
1	CytokinesIBA 01/2013
1	Transaminases (Aminotransferases)IBA 01/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2013
1	GDC-0152IBA 01/2013
1	cobimetinibIBA 06/2012
1	Caspase 3 (Caspase-3)IBA 05/2012
1	ThiophenesIBA 10/2011
1	LigandsIBA 07/2011
1	N- (3- (6- (4- (1,4- dimethyl- 3- oxopiperazin- 2- yl)phenylamino)- 4- methyl- 5- oxo- 4,5- dihydropyrazin- 2- yl)- 2- methylphenyl)- 4,5,6,7- tetrahydrobenzo(b)thiophene- 2- carboxamideIBA 07/2011
1	N- (4- (3- (1- ethyl- 3- fluoropiperidine- 4- ylamino)- 1H- pyrazolo(3,4- b)pyridin- 4- yloxy)- 3- fluorophenyl)- 2- (4- fluorophenyl)- 3- oxo- 2,3- dihydropyridazine- 4- carboxamideIBA 04/2011
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 09/2010
1	Proline (L-Proline)FDA Link 09/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2010
1	Tumor Biomarkers (Tumor Markers)IBA 09/2010
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2009
1	Fas Ligand Protein (Fas Ligand)IBA 12/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2009
1	Thyroid HormonesIBA 04/2009
1	XenobioticsIBA 04/2009
1	2- (4- (1- (hydroxyimino)- 2,3- dihydro- 1H- inden- 5- yl)- 3- (pyridin- 4- yl)- 1H- pyrazol- 1- yl)ethan- 1- olIBA 04/2009
1	thyroxine glucuronideIBA 04/2009
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2009
1	CaspasesIBA 03/2009
1	4- (3- pentylamino)- 2,7- dimethyl- 8- (2- methyl- 4- methoxyphenyl)pyrazolo(1,5- a)pyrimidineIBA 04/2004
1	BenzodiazepinesIBA 04/2004
1	Alprazolam (Xanax)FDA LinkGeneric 04/2004
1	Corticotropin-Releasing HormoneIBA 04/2004
1	Polyglycolic Acid (Polyglycolide)IBA 12/2002
1	GelatinIBA 12/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2013
1	Intravenous Administration 04/2014
1	Transplantation 06/2006